These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32367334)

  • 1. Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma.
    Duan K; Gucer H; Kefeli M; Asa SL; Winer DA; Mete O
    Endocr Pathol; 2020 Sep; 31(3):231-238. PubMed ID: 32367334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
    Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
    Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor and endocan expression in adrenal cortical tumors and their relationship with histopathological prognostic parameters.
    Karaköse M; Can M; Kocabaş M; Hasan Esen H; Kulaksızoğlu M; Karakurt F
    Endocr J; 2024 Aug; 71(8):789-797. PubMed ID: 38945931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
    Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A; Min IM; Crowley MJP; Panjwani SJ; Finnerty BM; Scognamiglio T; Liu YF; Whitsett TG; Garg S; Demeure MJ; Elemento O; Zarnegar R; Fahey TJ
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of adrenal cortical tumors.
    Kim HM; Lee YK; Koo JS
    Expert Rev Proteomics; 2016 Aug; 13(8):747-55. PubMed ID: 27385106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
    Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
    Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence.
    Glover AR; Zhao JT; Ip JC; Lee JC; Robinson BG; Gill AJ; Soon PS; Sidhu SB
    Endocr Relat Cancer; 2015 Feb; 22(1):99-109. PubMed ID: 25595289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of the
    Scicluna P; Caramuta S; Kjellin H; Xu C; Fröbom R; Akhtar M; Gao J; Shi H; Kjellman M; Almgren M; Höög A; Zedenius J; Ekström TJ; Bränström R; Lui WO; Larsson C
    Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36169175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
    Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
    Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma.
    Poli G; Ceni E; Armignacco R; Ercolino T; Canu L; Baroni G; Nesi G; Galli A; Mannelli M; Luconi M
    Oncotarget; 2015 Mar; 6(8):5695-706. PubMed ID: 25691058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA Expression in Adrenal Cortical Neoplasms.
    Shiyanbola O; Hardin H; Hu R; Eickhoff JC; Lloyd RV
    Endocr Pathol; 2020 Dec; 31(4):385-391. PubMed ID: 32725507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
    Pereira SS; Máximo V; Coelho R; Batista R; Soares P; Guerreiro SG; Sobrinho-Simões M; Monteiro MP; Pignatelli D
    J Cell Biochem; 2017 Aug; 118(8):2064-2071. PubMed ID: 27886397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
    Chabre O; Libé R; Assie G; Barreau O; Bertherat J; Bertagna X; Feige JJ; Cherradi N
    Endocr Relat Cancer; 2013 Aug; 20(4):579-94. PubMed ID: 23756429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.